WSBK:NASDAQWinchester Bancorp, Inc. Analysis
Data as of 2026-05-28 - not real-time
$12.77
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Winchester Bancorp is trading just above its 20‑day SMA (12.74) and just below its 50‑day SMA (12.83), placing the stock in a narrow neutral band between a clear support at $12.59 and resistance at $12.93. Technical indicators show a near‑neutral RSI (≈50) and a bullish MACD crossover, suggesting modest upside momentum in the short run. The company’s revenue surged 35% year‑over‑year and it maintains solid operating margins (≈26%), but profitability metrics such as ROE (2.3%) and ROA (0.2%) remain weak. Valuation is a major concern: the trailing PE of 49x dwarfs the industry average of 16.6x, and a discounted cash‑flow model values the stock at roughly $6.93, less than half the current price. Insider confidence adds a positive note, with director John Snow purchasing 6,110 shares (≈$78k) in early May, indicating belief in the company’s fundamentals. However, the balance sheet shows $147 M of debt offset by $54 M of cash, and the lack of any dividend underscores limited cash return to shareholders. The broader market sentiment is extremely bullish (Fear & Greed Index 92), which may be inflating price expectations beyond fundamentals. Given the low beta (≈0.03) the stock is insulated from market swings, yet regional bank exposure brings sector‑specific credit and regulatory risks. In this mixed environment, the stock appears overvalued despite short‑term technical support and insider buying.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price near technical support with bullish MACD signal
- Recent insider purchase indicating confidence
- Low beta reducing market volatility exposure
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong revenue growth but weak ROE/ROA
- Valuation still far above DCF fair value
- Sector credit risk for regional banks
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- Persistently high PE relative to peers
- Limited cash generation and no dividend
- Elevated regulatory and credit risk in banking sector
Key Metrics & Analysis
Financial Health
Revenue Growth35.10%
Profit Margin9.51%
P/E Ratio49.1
ROE2.26%
ROA0.23%
P/B Ratio1.0
Op. Cash Flow$6.2M
Industry P/E16.6
Technical Analysis
TrendNeutral
RSI50.0
Support$12.59
Resistance$12.93
MA 20$12.74
MA 50$12.83
MA 200$11.03
MACDBullish
VolumeDecreasing
Fear & Greed Index92.34
Valuation
Fair Value$6.93
GradeOvervalued
TypeBlend
Risk Assessment
Beta0.03
Volatility7.07%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
ZIONP
Zions Bancorporation N.A. - Depositary Shares each representing a 1/40th ownership interest in a share of Series A Floating-Rate Non-Cumulative Perpetual Prefer
STOCKZION
Zions Bancorporation N.A.
STOCKYOU
Clear Secure, Inc.
STOCKABCL
AbCellera Biologics Inc.
STOCKWETH
Wetouch Technology Inc.
STOCKSOPA
Society Pass Incorporated
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.